Contact
Please use this form to send email to PR contact of this press release:
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
TO:
Please use this form to send email to PR contact of this press release:
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
TO: